News Articles Tagged: Cancer Drug Metabolism

Targeting Cancer Metabolism: The Promise of GLS1 Inhibitors like CB-839

Examine the promise of GLS1 inhibitors, specifically CB-839, in targeting cancer's metabolic vulnerabilities for new treatment strategies.

Exploring the Therapeutic Potential of GLS1 Inhibitors: The Case of CB-839

Discover the therapeutic potential of GLS1 inhibitors like CB-839 in targeting cancer's metabolic vulnerabilities, with insights for drug developers.

Understanding Glutaminase Inhibition: The Role of CB-839 in Cancer Metabolism

Explore how CB-839, a potent GLS1 inhibitor, is revolutionizing cancer metabolism research by targeting glutamine addiction in cancer cells.

The Role of Pharmacokinetics and Metabolism in Irinotecan Hydrochloride Therapy

An in-depth look at the pharmacokinetics and metabolic pathways of Irinotecan Hydrochloride, explaining how its active metabolite SN-38 contributes to its efficacy and how genetic factors influence patient response.

Navigating the Pharmacokinetics of Docetaxel Anhydrous

A detailed examination of how Docetaxel Anhydrous is absorbed, distributed, metabolized, and excreted in the body, crucial for effective cancer treatment.